BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22864349)

  • 1. [Dynamic analysis of pharmacokinetics of orally administered drugs using positron emission tomography].
    Kataoka M
    Yakugaku Zasshi; 2012; 132(8):911-7. PubMed ID: 22864349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic analysis of GI absorption and hepatic distribution processes of telmisartan in rats using positron emission tomography.
    Kataoka M; Takashima T; Shingaki T; Hashidzume Y; Katayama Y; Wada Y; Oh H; Masaoka Y; Sakuma S; Sugiyama Y; Yamashita S; Watanabe Y
    Pharm Res; 2012 Sep; 29(9):2419-31. PubMed ID: 22618800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [¹¹C]telmisartan.
    Takashima T; Hashizume Y; Katayama Y; Murai M; Wada Y; Maeda K; Sugiyama Y; Watanabe Y
    Mol Pharm; 2011 Oct; 8(5):1789-98. PubMed ID: 21812443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of gastrointestinal absorption and biodistribution of an orally administered probe using positron emission tomography in humans.
    Shingaki T; Takashima T; Wada Y; Tanaka M; Kataoka M; Ishii A; Shigihara Y; Sugiyama Y; Yamashita S; Watanabe Y
    Clin Pharmacol Ther; 2012 Apr; 91(4):653-9. PubMed ID: 22378159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging of the gastrointestinal absorption of orally administered drugs in conscious and anesthetized rats.
    Yamashita S; Takashima T; Kataoka M; Oh H; Sakuma S; Takahashi M; Suzuki N; Hayashinaka E; Wada Y; Cui Y; Watanabe Y
    J Nucl Med; 2011 Feb; 52(2):249-56. PubMed ID: 21233189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic analysis of fluid distribution in the gastrointestinal tract in rats: positron emission tomography imaging after oral administration of nonabsorbable marker, [(18)F]Deoxyfluoropoly(ethylene glycol).
    Takashima T; Shingaki T; Katayama Y; Hayashinaka E; Wada Y; Kataoka M; Ozaki D; Doi H; Suzuki M; Ishida S; Hatanaka K; Sugiyama Y; Akai S; Oku N; Yamashita S; Watanabe Y
    Mol Pharm; 2013 Jun; 10(6):2261-9. PubMed ID: 23600944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body distribution and radiation dosimetry of [11C]telmisartan as a biomarker for hepatic organic anion transporting polypeptide (OATP) 1B3.
    Shimizu K; Takashima T; Yamane T; Sasaki M; Kageyama H; Hashizume Y; Maeda K; Sugiyama Y; Watanabe Y; Senda M
    Nucl Med Biol; 2012 Aug; 39(6):847-53. PubMed ID: 22421430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the attenuating effect of telmisartan against radiation-induced intestinal injury using
    Fooladi M; Shirazi A; Sheikhzadeh P; Amirrashedi M; Ghahramani F; Cheki M; Khoobi M
    Int J Radiat Biol; 2023; 99(3):446-458. PubMed ID: 35930426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Complicated Nonlinear Pharmacokinetics of Orally Administered Telmisartan in Rats Using a Stable Isotope-IV Method.
    Minami K; Higashino H; Kataoka M; Togashi K; Mutaguchi K; Yamashita S
    J Pharm Sci; 2019 Aug; 108(8):2774-2780. PubMed ID: 30922857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative investigation of hepatobiliary transport of [
    Maeda K; Ohnishi A; Sasaki M; Ikari Y; Aita K; Watanabe Y; Kusuhara H; Sugiyama Y; Senda M
    Drug Metab Pharmacokinet; 2019 Oct; 34(5):293-299. PubMed ID: 31564410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target-mediated drug disposition and OATP1B3-mediated hepatic uptake in a physiologically based model.
    Tsuchitani T; Tomaru A; Aoki Y; Ishiguro N; Tsuda Y; Sugiyama Y
    CPT Pharmacometrics Syst Pharmacol; 2024 May; ():. PubMed ID: 38745377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.
    Ishiguro N; Maeda K; Saito A; Kishimoto W; Matsushima S; Ebner T; Roth W; Igarashi T; Sugiyama Y
    Drug Metab Dispos; 2008 Apr; 36(4):796-805. PubMed ID: 18180273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography (PET) for assessing aerosol deposition of orally inhaled drug products.
    Dolovich MB; Bailey DL
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25 Suppl 1():S52-71. PubMed ID: 23215847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
    Takahashi T; Uno Y; Yamazaki H; Kume T
    Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human positron emission tomography with oral 11C-vinpocetine].
    Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B
    Orv Hetil; 2003 Nov; 144(46):2271-6. PubMed ID: 14702922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers.
    Stangier J; Schmid J; Türck D; Switek H; Verhagen A; Peeters PA; van Marle SP; Tamminga WJ; Sollie FA; Jonkman JH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1312-22. PubMed ID: 11185629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability.
    Sawamoto T; Haruta S; Kurosaki Y; Higaki K; Kimura T
    J Pharm Pharmacol; 1997 Apr; 49(4):450-7. PubMed ID: 9232547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography.
    Kamei N; Morishita M; Kanayama Y; Hasegawa K; Nishimura M; Hayashinaka E; Wada Y; Watanabe Y; Takayama K
    J Control Release; 2010 Aug; 146(1):16-22. PubMed ID: 20457194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of P-Glycoprotein Inhibition or Deficiency at the Blood-Brain Barrier on (18)F-2-Fluoro-2-Deoxy-D-glucose ( (18)F-FDG) Brain Kinetics.
    Tournier N; Saba W; Goutal S; Gervais P; Valette H; Scherrmann JM; Bottlaender M; Cisternino S
    AAPS J; 2015 May; 17(3):652-9. PubMed ID: 25716150
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.